secwatch.observer — SEC 8-K summary
======================================

Issuer:     NextCure, Inc. (NXTC)
CIK:        0001661059
Form:       8-K
Filed at:   2025-07-14T23:59:59+00:00
Accession:  0001558370-25-009214
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NextCure effects 1:12 reverse stock split effective July 14, 2025
-----------------------------------------------------------------

- Reverse stock split ratio 1:12, effective 12:01 a.m. ET on July 14, 2025.
- Stockholders approved split ratio range of 1:5 to 1:15; Board chose 1:12.
- No fractional shares; cash payment for fractional shares based on closing price prior to effective date.
- Authorized shares remain 100 million; all outstanding options, warrants, and equity plans adjusted proportionally.
- Common stock continues trading under ticker NXTC on Nasdaq Global Select Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661059/000155837025009214/0001558370-25-009214-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661059/000155837025009214/nxtc-20250714x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-009214

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer